Mass testing is a euphemism for population screening. A range of experts who care about screening for the […]
Combination treatment scored EU approval earlier this year
Trial will evaluate whether Mavenclad can slow the rate of upper limb disability progression
CGRP antagonist approved to prevent migraine in adults with episodic and chronic migraine
New findings from phase 2 study published in The Lancet
Updated Date: Thu, 12 Nov 2020 00:00:00 EST
Updated Date: Thu, 12 Nov 2020 00:00:00 EST
Updated Date: Thu, 12 Nov 2020 00:00:00 EST
Updated Date: Thu, 12 Nov 2020 00:00:00 EST
Updated Date: Thu, 12 Nov 2020 00:00:00 EST